Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19889263 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL19889196 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL1686159 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL29913036 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL11197203 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL7989065 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL31629817 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL14735789 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL30006581 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL1686154 | 0.97 | TDP1 (0.71) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240367116-A1 | LIGAND-MODIFIED FILTER AND METHODS FOR REDUCING METALS FROM LIQUID COMPOSITIONS | ENTEGRIS, INC. | 2024-11-07 | — | — | US | claimed |
| CN-111545075-B | Ligand-modified filter materials, composite membranes, and methods for reducing metals from liquid compositions | 恩特格里斯公司 | 2023-08-01 | — | — | CN | claimed |
| US-11465104-B2 | Ligand-modified filter and methods for reducing metals from liquid compositions | ENTEGRIS, INC. (US) | 2022-10-11 | — | — | US | claimed |
| EP-3921067-A1 | LIGAND-MODIFIED FILTER AND METHODS FOR REDUCING METALS FROM LIQUID COMPOSITIONS | Entegris, Inc. (US) | 2021-12-15 | — | — | EP | claimed |
| WO-2020163181-A1 | LIGAND-MODIFIED FILTER AND METHODS FOR REDUCING METALS FROM LIQUID COMPOSITIONS | ENTEGRIS, INC. (US) | 2020-08-13 | — | — | WO | claimed |
| US-20200254398-A1 | LIGAND-MODIFIED FILTER AND METHODS FOR REDUCING METALS FROM LIQUID COMPOSITIONS | MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT | 2020-08-13 | — | — | US | claimed |
| EP-4225479-B1 | FILTRATION MEMBRANE SYSTEMS, AND METHODS FOR PRODUCING PURIFIED WATER | ENTEGRIS INC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3700578-B1 | SYSTEMS FOR RENAL FUNCTION DETERMINATION | MEDIBEACON INC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250144574-A1 | FILTRATION MEMBRANES, SYSTEMS, AND METHODS FOR PRODUCING PURIFIED WATER | ENTEGRIS, INC. | 2025-05-08 | — | — | US | disclosed |
| US-20240367116-A1 | LIGAND-MODIFIED FILTER AND METHODS FOR REDUCING METALS FROM LIQUID COMPOSITIONS | ENTEGRIS, INC. | 2024-11-07 | — | — | US | disclosed |
| EP-4225479-A1 | FILTRATION MEMBRANES, SYSTEMS, AND METHODS FOR PRODUCING PURIFIED WATER | Entegris, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-111545075-B | Ligand-modified filter materials, composite membranes, and methods for reducing metals from liquid compositions | 恩特格里斯公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20230173111-A1 | COMPOSITIONS AND SYSTEMS FOR RENAL FUNCTION DETERMINATION | MEDIBEACON INC. | 2023-06-08 | — | — | US | disclosed |
| CN-105503613-B | A kind of method that direct ammonification of polyol prepares polyamine | 中国科学院大连化学物理研究所 | 2018-06-26 | — | — | CN | disclosed |
| CN-105435842-B | A kind of homogeneous catalyst and its application in polyol aminating reaction | 中国科学院大连化学物理研究所 | 2017-11-28 | — | — | CN | disclosed |
| CN-105498834-B | A kind of heterogeneous catalyst and its application in polyol aminating reaction | 中国科学院大连化学物理研究所 | 2017-11-10 | — | — | CN | disclosed |
| CN-105503613-A | Method for preparing polyamine by direct ammoniation of polyhydroxy compound | DALIAN INST CHEMICAL PHYSICS CAS | 2016-04-20 | — | — | CN | disclosed |
| CN-105498834-A | Heterogeneous catalyst and application of heterogeneous catalyst in ammoniation reaction of polyhydroxy compound | DALIAN INST CHEMICAL PHYSICS CAS | 2016-04-20 | — | — | CN | disclosed |
| CN-105435842-A | Homogeneous catalyst and application thereof in polyhydroxy compound ammoniation reaction | DALIAN INST CHEMICAL PHYSICS CAS | 2016-03-30 | — | — | CN | disclosed |
| CN-1058519-A | Water-soluble pigment obtained from monascorubin and rubropunctatin as food colorant | UOP INC (US) | 1992-02-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173111-A1 | COMPOSITIONS AND SYSTEMS FOR RENAL FUNCTION DETERMINATION | GLS, ATP6V1B1, REN | LMNA 1618/4885L3MBTL1 4690/4885TDP1 2576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.